Literature DB >> 6155813

The effects of positive end-expiratory pressure on right and left ventricular performance.

J L Robotham, W Lixfeld, L Holland, D MacGregor, B Bromberger-Barnea, S Permutt, J L Rabson.   

Abstract

The cardiovascular effects of positive end-expiratory pressure (PEEP) were studied in mechanically ventilated, vagotomized, Beta-blocked, anesthetized dogs. To compensate for the effect of PEEP on decreasing systemic venous return, acute plasma volume expansion was accomplished returning stroke volume and cardiac output to control values. Left and right ventricular filling pressures (LVFP and RVFP) and aortic pressure were measured relative to pressure (transmural pressure). Ventricular performance was assessed by comparing the transmural ventricular filling pressures at similar stroke volumes. Studies were performed on individual dogs with increasing LVFP produced by Beta-blockade, volume expansion, and obstruction of the descending thoracic aorta. Utilizing these methods we observed that for a given cardiac output, transmural LVFP was higher on PEEP compared to a control state with both normal and elevated control LVFP. On the right side, for a given cardiac output, RVFP was elevated only when the control LVFP was elevated. Our results suggest a nonneuronal adverse effect of PEEP on both left and right ventricular performance. This effect is probably due to mechanical heart-lung interaction since left ventricular (LV) dp/dt showed no change.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6155813     DOI: 10.1164/arrd.1980.121.4.677

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

1.  Coronary haemodynamics and myocardial metabolism during weaning from mechanical ventilation in cardiac surgical patients.

Authors:  S Elia; P Liu; A Hilgenberg; C Skourtis; D Lappas
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

2.  Left ventricular external constraint: relationship between pericardial, pleural and esophageal pressures during positive end-expiratory pressure and volume loading in dogs.

Authors:  I Kingma; O A Smiseth; M A Frais; E R Smith; J V Tyberg
Journal:  Ann Biomed Eng       Date:  1987       Impact factor: 3.934

3.  Artificial ventilation and the heart.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-08

4.  Cardiovascular effects of ventilation with positive expiratory airway pressure.

Authors:  P K Smith; G S Tyson; J W Hammon; C O Olsen; R A Hopkins; G W Maier; D C Sabiston; J S Rankin
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

5.  Myocardial transmural pressure in ventilated patients.

Authors:  K Skarvan; J Hasse; G Wolff
Journal:  Intensive Care Med       Date:  1981       Impact factor: 17.440

6.  Haemodynamic effects of pressure support and PEEP ventilation by nasal route in patients with stable chronic obstructive pulmonary disease.

Authors:  N Ambrosino; S Nava; A Torbicki; G Riccardi; C Fracchia; C Opasich; C Rampulla
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

7.  Relief of hypoxemia contributes to a reduction in cardiac index related to the use of positive end-expiratory pressure.

Authors:  M Borelli; R Fumagalli; F Bernasconi; M Cereda; L Gattinoni; A Pesenti
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

8.  Right atrial pressure affects the interaction between lung mechanics and right ventricular function in spontaneously breathing COPD patients.

Authors:  Bart Boerrigter; Pia Trip; Harm Jan Bogaard; Herman Groepenhoff; Frank Oosterveer; Nico Westerhof; Anton Vonk Noordegraaf
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

9.  Positive end-expiratory pressure and variable ventilation in lung-healthy rats under general anesthesia.

Authors:  Luciana M Camilo; Mariana B Ávila; Luis Felipe S Cruz; Gabriel C M Ribeiro; Peter M Spieth; Andreas A Reske; Marcelo Amato; Antonio Giannella-Neto; Walter A Zin; Alysson R Carvalho
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.